Literature DB >> 24215615

Epigenetics and the IRFs: a complex interplay in the control of immunity and autoimmunity.

Inez Rogatsky1, Uma Chandrasekaran, Michela Manni, Woelsung Yi, Alessandra B Pernis.   

Abstract

Effective immune responses require the coordinated activation and differentiation of several cell types, including T-cells, B-cells and myeloid cells. Abnormalities in the appropriate regulation of these processes underlie the pathogenesis of many autoimmune disorders, including systemic lupus erythematosus (SLE). Recent studies have revealed that, in addition to sequence-specific DNA-binding factors, the chromatin landscape of a cell can play a pivotal role in controlling these processes and in regulating the onset of autoimmunity. Interferon regulatory factors (IRFs) are emerging as critical regulators of the activation and differentiation of immune cells and deregulation in the expression and/or function of members of the IRF family has increasingly been linked to the pathogenesis of lupus. In this review, we will provide a brief overview of the role of different IRFs in immune responses and SLE development and discuss studies, which highlight the intricate relationship of this family of transcription factors with the epigenetic machinery.

Entities:  

Keywords:  Autoimmunity; IRF; SLE; epigenetics; transcription factors

Mesh:

Substances:

Year:  2013        PMID: 24215615     DOI: 10.3109/08916934.2013.853050

Source DB:  PubMed          Journal:  Autoimmunity        ISSN: 0891-6934            Impact factor:   2.815


  7 in total

Review 1.  Interferon regulatory factor signaling in autoimmune disease.

Authors:  Bharati Matta; Su Song; Dan Li; Betsy J Barnes
Journal:  Cytokine       Date:  2017-03-07       Impact factor: 3.861

2.  CXCL4 synergizes with TLR8 for TBK1-IRF5 activation, epigenomic remodeling and inflammatory response in human monocytes.

Authors:  Chao Yang; Mahesh Bachu; Yong Du; Caroline Brauner; Ruoxi Yuan; Marie Dominique Ah Kioon; Giancarlo Chesi; Franck J Barrat; Lionel B Ivashkiv
Journal:  Nat Commun       Date:  2022-06-14       Impact factor: 17.694

Review 3.  Autoimmunity in 2014.

Authors:  Carlo Selmi
Journal:  Clin Rev Allergy Immunol       Date:  2015-10       Impact factor: 8.667

4.  Division of labor between IRF1 and IRF2 in regulating different stages of transcriptional activation in cellular antiviral activities.

Authors:  Gang Ren; Kairong Cui; Zhiying Zhang; Keji Zhao
Journal:  Cell Biosci       Date:  2015-04-18       Impact factor: 7.133

5.  IRF4-Dependent and IRF4-Independent Pathways Contribute to DC Dysfunction in Lupus.

Authors:  Michela Manni; Sanjay Gupta; Briana G Nixon; Casey T Weaver; Rolf Jessberger; Alessandra B Pernis
Journal:  PLoS One       Date:  2015-11-06       Impact factor: 3.240

6.  Regulation of age-associated B cells by IRF5 in systemic autoimmunity.

Authors:  Michela Manni; Sanjay Gupta; Edd Ricker; Yurii Chinenov; Sung Ho Park; Man Shi; Tania Pannellini; Rolf Jessberger; Lionel B Ivashkiv; Alessandra B Pernis
Journal:  Nat Immunol       Date:  2018-02-26       Impact factor: 25.606

7.  Selective dysregulation of ROCK2 activity promotes aberrant transcriptional networks in ABC diffuse large B-cell lymphoma.

Authors:  Edd Ricker; Akanksha Verma; Rossella Marullo; Sanjay Gupta; Chao Ye; Tania Pannellini; Michela Manni; Wayne Tam; Giorgio Inghirami; Olivier Elemento; Leandro Cerchietti; Alessandra B Pernis
Journal:  Sci Rep       Date:  2020-08-04       Impact factor: 4.379

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.